Targeting macrophages for therapeutic and diagnostic purposes is an attractive approach applicable to multiple diseases. Here, we present a theranostic nanoemulsion platform for simultaneous delivery of an anti-inflammatory drug (celecoxib) to macrophages and monitoring of macrophage migration patterns by optical imaging, as measurement of changes in inflammation. The anti-inflammatory effect of the theranostic nanoemulsions was evaluated in a mouse inflammation model induced with complete Freund's adjuvant (CFA). Nanoemulsions showed greater accumulation in the inflamed vs. control paw, with histology confirming their specific localization in CD68 positive macrophages expressing cyclooxygenase-2 (COX-2) compared to neutrophils. With a single dose administration of the celecoxib-loaded theranostic, we observed a reduction in fluorescence in the paw with time, corresponding to a reduction in macrophage infiltration. Our data strongly suggest that delivery of select agents to infiltrating macrophages can potentially lead to new treatments of inflammatory diseases where macrophage behavior changes are monitored in vivo.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554801 | PMC |
| http://dx.doi.org/10.1016/j.clim.2015.04.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CD63 as novel target for nanoemulsion-based F MRI imaging and drug delivery to activated cardiac fibroblasts.
Theranostics
January 2025
Department of Molecular Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Cardiac fibroblasts are activated following myocardial infarction (MI) and cardiac fibrosis is a major driver of the growing burden of heart failure. A non-invasive targeting method for activated cardiac fibroblasts would be advantageous because of their importance for imaging and therapy. Targeting was achieved by linking a 7-amino acid peptide (EP9) to a perfluorocarbon-containing nanoemulsion (PFC-NE) for visualization by F-combined with H-MRI.
View Article and Find Full Text PDFCollagen-Based Nanoparticles as Drug Delivery System in Wound Healing Applications.
Int J Nanomedicine
November 2024
Department of Pharmacy Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
Background: Conventional wound dressings often adhere to wounds and can cause secondary injury due to their lack of anti-inflammatory and antibacterial properties. In contrast, collagen-based nanoparticles (NPs) as drug delivery systems exhibit both biocompatibility and biodegradability, presenting a promising avenue for accelerating wound healing processes.
Aims Of Study: This review aims to provide a comprehensive overview of the mechanisms involved in wound healing, description of the attributes of ideal wound dressings, understanding of wound healing efficacy of collagen, exploring NPs-mediated drug delivery mechanisms in wound therapy, detailing the synthesis and fabrication techniques of collagen-based NPs, and delineating the applications of various collagen-based NPs infused wound dressings on wound healing.
Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.
Mol Ther
December 2024
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address:
Article Synopsis
- * Researchers have found that a combination of a nanoemulsion and an RNA-based adjuvant, when used in intranasal vaccination, can enhance both systemic and mucosal immune responses significantly compared to traditional vaccination methods.
- * The study shows that a strategy of priming with intramuscular mRNA vaccines followed by an intranasal boost can lead to stronger immune responses, particularly in the upper respiratory tract, offering better protection against various SARS-CoV-2 variants.
MRI detection of free-contrast agent nanoparticles.
Magn Reson Med
February 2025
Molecular and Preclinical Imaging Centers, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Article Synopsis
- The research explores a new way to visualize nanoparticles in medical imaging using MRI and MRS techniques, specifically focusing on detecting natural proton signals in commonly used nanosystems.
- Three different nanosystems (lipid-based micelles, liposomes, and perfluorocarbon-based nanoemulsions) were created and characterized, with the perfluorocarbon-based nanoemulsion showing the best performance in signal detection.
- This method allows for the detection of nanoparticles without needing additional probes, indicating a significant advancement in non-invasive imaging for diagnostics and treatments in biomedical applications.
Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy.
Pharmaceutics
September 2024
Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.
Article Synopsis
- Theranostics combines diagnostics and therapeutics to improve precision medicine by tailoring treatments based on real-time data.
- Lipid-based nanocarriers are highlighted for their biodegradability and targeting capabilities, showing promise in cancer theranostics while facing challenges in enhancing their in vivo performance.
- The review emphasizes the need for multidisciplinary collaboration to overcome barriers such as regulatory issues, high costs, and technological integration for effective clinical application of these nanocarriers.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!